Advanta bioKEMIX and Resolkem Form Joint Venture to Strengthen High-Purity Solvent Manufacturing in India

Advanta bioKEMIX Expands Manufacturing Presence Through New Partnership

Advanta bioKEMIX, the Indian subsidiary of the global bioKEMIX network, has announced a strategic joint venture with Goa-based solvent manufacturer Resolkem. The move is aimed at strengthening the company's manufacturing capabilities and supporting its long-term vision of building an innovation-driven chemical manufacturing ecosystem in India.
The partnership brings together Advanta bioKEMIX's global reach and supply chain expertise with Resolkem's experience in producing high-purity GCHS solvents for specialized industries.

New Company Established Under Joint Venture

As part of the agreement, a new company named Resolkem Private Limited has been incorporated.
The new entity is jointly owned by Advanta bioKEMIX and Anand Malage, the founder of Resolkem and a pharmaceutical industry veteran previously associated with Cipla.
Under the new structure, Resolkem Private Limited will acquire and operate the existing business, manufacturing operations, and equipment that were previously managed under Resolkem's sole proprietorship model.
The transition is expected to provide a stronger platform for future expansion and growth.

Combining Manufacturing Expertise with Global Market Access

The joint venture is designed to leverage the strengths of both partners.
Resolkem contributes technical know-how, product development capabilities, and expertise in manufacturing high-purity solvents. Advanta bioKEMIX brings global distribution channels, supply chain integration capabilities, and access to international markets through the wider bioKEMIX network.
Together, the companies plan to build a scalable manufacturing platform focused on serving customers across several industries.
These include pharmaceuticals, biotechnology, life sciences, specialty chemicals, and advanced materials.

Focus on High-Purity Solvents for Critical Industries

Demand for high-purity solvents continues to grow as industries place greater emphasis on quality, compliance, and performance.
Pharmaceutical and biotechnology companies, in particular, require highly purified solvents for research, development, and manufacturing activities.
Through Resolkem Private Limited, the partners aim to strengthen their position in this segment and provide reliable supply solutions to customers in India and international markets.
The company intends to focus on delivering products that meet the stringent quality standards required by highly regulated industries.

Addressing Global Supply Chain Challenges

The partnership comes at a time when chemical manufacturers and end users around the world are looking for more resilient and diversified supply chains.
In recent years, businesses have increasingly focused on reducing supply chain risks and ensuring consistent access to critical raw materials and specialty chemicals.
By combining local manufacturing strength with global market connectivity, Resolkem Private Limited aims to position itself as a dependable supplier of high-purity solvents for customers worldwide.
The venture is expected to support customers seeking alternative sourcing options while maintaining high quality and reliability standards.

Strategic Step for Advanta bioKEMIX

For Advanta bioKEMIX, the joint venture represents another step in its strategy of investing in manufacturing partnerships that support long-term growth.
The company has been focused on creating an integrated ecosystem that combines manufacturing, innovation, supply chain efficiency, and global distribution.
By partnering with experienced manufacturers such as Resolkem, Advanta bioKEMIX aims to strengthen its product portfolio while creating additional value for customers across the chemical and life sciences sectors.
The company believes such partnerships can help improve supply chain resilience, encourage innovation, and support sustainable business growth in an increasingly competitive global market.

Industry Veteran Anand Malage Joins Growth Initiative

A key part of the partnership is the involvement of Anand Malage, founder of Resolkem and a respected professional with deep experience in the pharmaceutical sector.
His background in chemical manufacturing and previous association with Cipla adds significant industry expertise to the venture.
With the formation of Resolkem Private Limited, both partners will work together to expand manufacturing capabilities, strengthen customer relationships, and build a stronger presence in the global high-purity solvent market.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!